The only international event dedicated to discussing regulatory, ethical and operational aspects of running clinical trials in Russia

13-14 November 2018

InterContinental Moscow Tverskaya Hotel

First speakers in 2018:

Mikhail Samsonov, Chief Medical Officer, R-Pharm
Mikhail Samsonov

Chief Medical Officer

R-Pharm

Vladimir Bulatov, Chief Scientific Officer, Novartis Pharma, Russia
Vladimir Bulatov

Chief Scientific Officer

Novartis Pharma, Russia

Dmitry Koloda, Medical Director, CIS, Takeda Pharmaceuticals
Dmitry Koloda

Medical Director, CIS

Takeda Pharmaceuticals

Alexander Obukhov, Head of Medical Department, Pharmstandard
Alexander Obukhov

Head of Medical Department

Pharmstandard

Konstantin Gudkov, Clinical Research Director, AstraZeneca Russia
Konstantin Gudkov

Clinical Research Director

AstraZeneca Russia

Natalia Vostokova, Chief Operating Officer, IPHARMA
Natalia Vostokova

Chief Operating Officer

IPHARMA

Roman Dray, Director, Clinical Development, GEROPHARM
Roman Dray

Director, Clinical Development

GEROPHARM

Olga Filon, Deputy Director, Strategic Development, Drugs Technology
Olga Filon

Deputy Director, Strategic Development

Drugs Technology

Ksenia Teplova-Bareysha, Country Head of Site Management, Bayer
Ksenia Teplova-Bareysha

Country Head of Site Management

Bayer

Tatiana Gorskaya, Regulatory Affairs & Pharmacovigilance Group Leader, Russia and CIS, Ipsen
Tatiana Gorskaya

Regulatory Affairs & Pharmacovigilance Group Leader, Russia and CIS

Ipsen

Vladimir Kovalev, Clinical Research Manager, Abbott Laboratories
Vladimir Kovalev

Clinical Research Manager

Abbott Laboratories

Yulia Linkova, Head of Clinical Development, Neurology, Nephrology and Orphan Diseases Unit and Drug Safety, Biocad
Yulia Linkova

Head of Clinical Development, Neurology, Nephrology and Orphan Diseases Unit and Drug Safety

Biocad

Igor Ivanov, General Director, Center for Monitoring and Clinical and Economic Expertise of Roszdravnadzor
Igor Ivanov

General Director

Center for Monitoring and Clinical and Economic Expertise of Roszdravnadzor

Tatiana Ivanova, Head of Medical Devices Monitoring Division, All-Russian Research and Test Institute of Medical Devices of Roszdravnadzor
Tatiana Ivanova

Head of Medical Devices Monitoring Division

All-Russian Research and Test Institute of Medical Devices of Roszdravnadzor

Konstantin Semenov, Quality Assurance Director, IPHARMA
Konstantin Semenov

Quality Assurance Director

IPHARMA

Marina Debryanskaya, Head of Clinical Trials Management, Russian Innovation Centre, Takeda Pharmaceuticals
Marina Debryanskaya

Head of Clinical Trials Management, Russian Innovation Centre

Takeda Pharmaceuticals

Vladimir Popov, Clinical Pharmacologist, NGHCI
Vladimir Popov

Clinical Pharmacologist

NGHCI "Scientific Clinical Centre", Russian Railways

Vera Berezina, General Director, Center of Clinical Trials
Vera Berezina

General Director

Center of Clinical Trials

Maria Nasonova, Executive Manager, ALMEDIS
Maria Nasonova

Executive Manager

ALMEDIS

Ekaterina Dokukina, Director, Clinical Studies Department, BIOCAD
Ekaterina Dokukina

Director, Clinical Studies Department

BIOCAD

Yunona Khomitskaya, Head of Medical Department, Servier
Yunona Khomitskaya

Head of Medical Department

Servier

Yuri Zhulev, Co-Chairman, Russian Patients Association
Yuri Zhulev

Co-Chairman

Russian Patients Association

Vladimir Dvoretskiy, Head of Site Management, Monitoring, Administering of Clinical Trials & Contract Management, Russia & CIS, AbbVie
Vladimir Dvoretskiy

Head of Site Management, Monitoring, Administering of Clinical Trials & Contract Management, Russia & CIS

AbbVie

Alexander Solodovnikov, Director, Project Management, Statandocs
Alexander Solodovnikov

Director, Project Management

Statandocs

New topics in the 2018 programme

  • What’s new in the clinical trials market in Russia and overseas in 2018?
  • Prospects for clinical research according to the common rules for the countries in the Eurasian Economic Union
  • New check lists of Roszdravnadzor: practical aspects
  • How to improve the quality of clinical research?
  • Clinical trials of gene therapy drugs
  • Paediatric clinical trials
  • Clinical trials in oncology
  • Clinical trials of medical devices
  • Value of real world evidence
  • Post-registration clinical trials
  • Big Data in clinical trials
  • eClinical Trials: experience and prospects
  • Patient centric approach in clinical trials
  • Risk management in clinical trials

150+ Attendees

Over 150 delegates from Russia and beyond annually attend the event. The Clinical Trials in Russia is recognised as a unique and valuable opportunity to meet with peers and discuss common challenges.

40+ Experts

AstraZeneca Russia, Novartis Pharma, R-Pharm, GSK, Roszdravnadzor, Quintiles, Pfizer H.C.P. Corporation, Les Laboratories Servier Representative Office, NovaMedica, Pharmstandart and many others

2-Day Programme

Topical and compact programme filled with interactive formats, panel discussions and debates, showcasing original viewpoints and innovative case studies


Sponsored by:

Supporting organisations & media